BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8587280)

  • 21. Renal failure with posttransplant renin-angiotensin mediated hypertension.
    Lifschitz MD; Rios M; Radwin HM; Bannayan GA
    Arch Intern Med; 1978 Sep; 138(9):1409-11. PubMed ID: 356793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE; Savikko J; Rintala JM; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
    Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
    Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
    Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
    Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management.
    Knoll GA
    Am J Kidney Dis; 2009 Dec; 54(6):1131-44. PubMed ID: 19726115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary protein and the renin-angiotensin system in chronic renal allograft rejection.
    Rosenberg ME; Salahudeen AK; Hostetter TH
    Kidney Int Suppl; 1995 Dec; 52():S102-6. PubMed ID: 8587269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pentoxifylline on graft function of renal transplant recipients complicated with chronic allograft nephropathy.
    Shu KH; Wu MJ; Chen CH; Cheng CH; Lian JD; Lu YS
    Clin Nephrol; 2007 Mar; 67(3):157-63. PubMed ID: 17390740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical correlates to chronic renal allograft rejection.
    Kasiske BL
    Kidney Int Suppl; 1997 Dec; 63():S71-4. PubMed ID: 9407426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of hypertension in chronic renal allograft dysfunction.
    Sanders CE; Curtis JJ
    Kidney Int Suppl; 1995 Dec; 52():S43-7. PubMed ID: 8587282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic renal allograft dysfunction: risk factors, immunology and prevention.
    Fadili W; Habib Allah M; Laouad I
    Arab J Nephrol Transplant; 2013 Jan; 6(1):45-50. PubMed ID: 23282234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of chronic renal allograft rejection.
    Lemström K; Koskinen P; Häyry P
    Kidney Int Suppl; 1995 Dec; 52():S2-10. PubMed ID: 8587277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular immune-mediated intravascular coagulation in chronic renal allograft rejection.
    Welters C; Duijvestijn A; Muller P; Emeis S; van Breda Vriesman P
    Transplant Proc; 1993 Oct; 25(5):2865-6. PubMed ID: 8212267
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term progression pattern of chronic allograft dysfunction among kidney transplant recipients.
    Khalkhali HR; Hajizadeh E; Kazemnejad A; Ghafari A
    Iran J Kidney Dis; 2010 Jul; 4(3):244-9. PubMed ID: 20622315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.
    Amuchastegui SC; Azzollini N; Mister M; Pezzotta A; Perico N; Remuzzi G
    J Am Soc Nephrol; 1998 Oct; 9(10):1948-55. PubMed ID: 9773797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.